New AppliedXL partners with Kalshi to bring verifiable resolution infrastructure to biopharma prediction markets Read the announcement →
COMPANY / RESEARCH / ARTICLE

AppliedXL Prediction Model: Six Clinical Trial Case Studies with Full Explainability

Six clinical trials tracked from first filing to outcome. Each case reconstructs how the model's probability shifted in response to registry events — and whether the final call matched reality. Covers Roche, Regeneron, Abivax, Akeso, Sanofi, and Praxis.

06 JUN 2026 · APPLIEDXL RESEARCH (APPLIEDXL) · INTERACTIVE

Six case studies
Read full overview
01

Primary Endpoint

Did the drug clear its primary efficacy hurdle?
Click on a node to see the model explanation
02

Clinical Significance

Was the treatment effect large enough to matter in practice?
Click on a node to see the model explanation
04

Regulatory Approval

Will the drug ultimately secure FDA approval?
Click on a node to see the model explanation

CONTINUE READING

PAPERAppliedXL Achieves State-of-the-Art Clinical Trial Prediction With Domain-Specific Agentic AIANALYSISClinical Trial Data as Alpha: Building a Biotech Quant Trading Model With Point-in-Time IntelligenceINTELLIGENCEAppliedXL Response to FDA Drug Repurposing Initiative: 5 Drugs With Clinical Evidence and No Commercial Champion

Explore Forecasts

APPLIEDXL RESEARCH

See what the platform reads before it becomes news.

Source-linked intelligence across regulated markets, scoped to your domain.

Get startedBack to research